VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review) by T. E. Byalik

Subjects: Get full text

Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer by Anna R. Schreiber, Stephen G. Smoots, Marilyn M. Jackson, Stacey M. Bagby, Evan D. Dus, Adrian T. A. Dominguez, Cameron A. Binns, Todd M. Pitts, Jennifer R. Diamond

Subjects: Get full text

Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia‐Induced Vulnerabilities in Multiple Myeloma by Seiichi Okabe, Yuya Arai, Yuko Tanaka, Akihiko Gotoh

Subjects: Get full text

Venetoclax-Based Regimens in CLL: Immunoglobulin G Levels, Absolute Neutrophil Counts, and Infectious Complications by Wojciech Szlasa, Monika Kisielewska, Anna Sobczyńska-Konefał, Emilia Jaskuła, Monika Mordak-Domagała, Jacek Kwiatkowski, Katarzyna Tatara, Agnieszka Kuś, Mateusz Sawicki, Izabela Dereń-Wagemann, Mariola Sędzimirska, Ugo Giordano, Jarosław Dybko

Subjects: Get full text

Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China by Rongrong Wang, Yanfen Li, Ran Zhang, Yuan Ren, Yifan Liu, Tianlin Wang, Jin Wu, Xiangjin Zheng, Shu Li, Yu Jing

Subjects: “…venetoclax…”
Get full text

ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress by Jenna L. Carter, Yongwei Su, Eman T. Al-Antary, Jianlei Zhao, Xinan Qiao, Guan Wang, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Steven A. Buck, Maik Hüttemann, Joshua E. Allen, Varun V. Prabhu, Jay Yang, Jeffrey W. Taub, Yubin Ge

Subjects: Get full text

A Population Pharmacokinetics Study of Venetoclax Concomitant with Voriconazole in Patients with Hematologic Malignancies by Yang J, Wang H, Liu D, Cao W, Xing H, Wang P

Subjects: “…venetoclax…”
Get full text

Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia by Yi Wang, Yingying Chen, Dongdong Ji, Ling Ge, Yu Zhang, Lixia Liu, Lei Jiang, Fengbo Jin, Leiming Xia

Subjects: “…Venetoclax…”
Get full text

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review by Xiaohong Liu, Xiujuan Zhang, Hongxia Shi

Subjects: Get full text

Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors by Dongyue Jiao, Kun Chang, Jiamin Jin, Yingji Chen, Mo Ren, Yucong Zhang, Kun Gao, Yaoting Xu, Lixin Wang, Chenji Wang

Subjects: Get full text

Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice by E. A. Dmitrieva, S. V. Voloshin, K. D. Kaplanov, V. Touliet, V. V. Zasypkina, O. V. Magdych, E. F. Klinushkina

Subjects: Get full text

EFFECTIVENESS OF VENETOСLAX IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (LITERATURE REVIEW) by V. V. Strugov, E. A. Stadnik, A. Yu. Zaritskey

Subjects: Get full text

First case report: near early T-cell precursor acute lymphoblastic leukemia with plasmacytoid dendritic cell proliferation effectively treated with Venetoclax plus HAG regimen by Jiongping Han, Dan Li, Hongqiang Luo, Zhe Chen, Yi Feng, Fang Liu, Liping Wang, Xin Huang, Weiying Feng

Subjects: Get full text

Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature revie... by Alaa Eldein Yahia, Ibrahim Motabi, Abdullah A. Alsakkaf, Kamal Alzahrani, Laila M. Alsuhaibani, Bilal Albtoosh, Abdullah Khaled AlBathi, Abdullah M. Alrajhi

Subjects: “…Venetoclax…”
Get full text

Efficacy and safety of venetoclax and azacitidine for acute myeloid leukemia in China: a real-world single-center study by Jie-Fei Bai, Ting Wang, Jiang-Tao Li, Chun-Li Zhang, Long Qian, Ya-Zi Yang, Xiao-Ya Yun, Jing-Jing Yin, Fei Zhao, Wei-Dong Ding, Bao-Li Xing, Shang-Yong Ning, Lei Pei, Xiao-Dong Xu, Hui Liu, Ru Feng

Subjects: Get full text

Treatment of elderly patients with acute myeloid leukemia: personal experience by L. T. Shimanovskaya, E. N. Misyurina, E. A. Baryakh, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, T. N. Tolstykh, D. E. Gagloeva

Subjects: Get full text

Effective treatment of peritoneal myeloid sarcoma with decitabine and venetoclax: A case report by Kavya Sudireddy, Minorvi Amin, Rafy Odeh, Patrick Svrcek, Salwa Khedr, Lloyd Hutchinson, Shyam A. Patel, Jan Cerny, Laurie Pearson

Subjects: Get full text

Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center by Ziyi Hao, Yingying Fei, Juan Chen, Sailan Huang, Li Wang, Youhuan Yu, Meiru Bian, Yejun Si, Xingxia Zhang, Xiaotian Yang, Bing Zhang, Yan Wan, Guoqiang Lin, Yanming Zhang

Subjects: Get full text

Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia by Yiming Cai, Jingwen Rui, Zhengwen Ding, Judan Xie, Zhou Jin, Jinyan Xiao, Yang Xu

Subjects: Get full text

Preventing and managing the toxicities associated with the combination therapy of ibrutinib and venetoclax in chronic lymphocytic leukaemia by Elżbieta Iskierka-Jażdżewska, Krzysztof Jamroziak, Tadeusz Robak, Bartosz Puła

Subjects: Get full text